Building a family when a father is living with HIV.

The short answer

Living with HIV is not, on its own, a reason to be turned away from fertility care. People living with HIV should not face categorical exclusion when experienced clinical resources and risk-reduction protocols are available. What follows is a real clinical pathway — specialist input, documentation, laboratory coordination, disclosure and counseling — and the eligibility decision belongs to the treating clinic, not to a website.

Start here

A diagnosis is not a disqualification

Professional guidance is clear that HIV status is not, by itself, an ethical ground for refusing fertility care. What matters is whether a particular program has the resources and the protocols to do this work well.

ASRM’s 2026 committee opinion on fertility care for LGBTQ+ individuals states that people living with HIV should not face categorical exclusion from fertility care when experienced clinical resources and risk-reduction protocols are available. The same opinion holds that sexual orientation alone is not an ethical reason to withhold fertility services, and that programs should evaluate clinical and psychosocial considerations without categorical exclusion.

That is a statement about how programs should reason. It is not a promise that every clinic offers every service. Some fertility centers have an infectious-disease partnership, an equipped laboratory and a written protocol. Others do not, and will refer rather than improvise. Neither answer is a verdict on you, and the practical task is to find the programs that are genuinely set up for this pathway — early, before you have committed to a donor timeline.

Individual evaluation still happens. An infectious-disease physician and the fertility clinic will look at your treatment history, current viral load, medications and general health. That evaluation is not a formality and it is not adversarial. It is the work that lets a well-resourced clinic say yes with confidence, and it is the same reason its answers to your questions will be specific rather than reassuring.

The pathway

What the journey may require

None of this is unusual for a clinic that does this work regularly. It feels unfamiliar mainly because so few surrogacy pages describe it at all.

Laboratory

How the specimen pathway works

This is the part intended fathers ask about most, and it is also the part where careful language matters most.

A specialized laboratory processes the semen sample to separate sperm from seminal fluid and cells, then tests the processed sample before it is used for insemination, IVF or ICSI. Programs that offer this pathway combine that processing with sustained viral suppression, infectious-disease oversight and their own clinic protocols. The purpose of the combination is risk reduction, and reduction is the honest word for it.

Be careful with confident language in either direction. Some pages write as though nothing could go wrong; others write as though nothing has changed in twenty-five years. Published clinical experience and professional guidance shape how these protocols are designed, but evidence drawn from a study population is not a prediction about one cycle. A clinician who answers a safety question with an absolute has stopped being useful to you, and a clinician who cannot describe the protocol at all has told you the same thing in a different way.

What you want from the clinic is procedural detail: which laboratory does the processing, what it tests for, what it reports back, how a result that does not clear is handled, and how all of that is explained to the gestational carrier and her physician. A program that answers those questions plainly has done this before.

Documentation

FDA eligibility, records and what the carrier is told

Two separate systems meet here: federal donor-eligibility rules covering the tissue, and informed consent for the person who will carry the pregnancy.

Egg and sperm donors require screening and testing under applicable FDA rules and professional guidance, and genetic screening does not eliminate all risk. For embryos or embryo-derived cells, FDA donor-eligibility rules generally address both the oocyte and semen donors, subject to regulatory exceptions. In practice that means the records covering your specimen and the donor’s oocytes have to be produced, reviewed and retained correctly, and that directed-use exceptions and labeling require clinic and legal review rather than a yes-or-no answer from a website.

The word "ineligible" appears in this system, and it frightens people more than it should. A donor-eligibility determination is a regulatory classification carrying its own documentation and labeling consequences. It is not a clinic’s judgment about your worth as a parent, and it is not automatically the end of a pathway. Ask your clinic and your attorney to explain how the determination will be documented in your case and what follows from it.

Separately from the federal paperwork, the gestational carrier has to be told. She controls consent to her own medical care, and consent that is not informed is not consent. Disclosure moves through the medical and legal process — her physician, her independent counsel, the psychological consultation, the contract — with time built in for her to ask questions and decide. Some carriers will proceed. Some will not. Both are legitimate answers, and a program that pushes her toward one of them is a program to leave.

Privacy

Where your status belongs, and where it does not

Disclosure to the people who need the information for a medical or legal decision is required. Broadcasting it is not, and no vendor should handle it casually.

HIV status does not belong in a public matching profile. It does not belong in ordinary event or marketing analytics, in a CRM field the whole staff can browse, in a shared inbox thread, or in a slide at a conference. It belongs in the medical record, in the legal file, and in the informed-consent conversation with the gestational carrier and her counsel — shared through the appropriate process, with the people who need it in order to make a decision.

That distinction is easy to state and easy for organizations to get wrong, which is exactly why it is worth asking about directly. A program that has thought it through can tell you who inside the organization sees the information, where it is stored, how it reaches the clinic and the carrier’s team, and what happens to it afterwards. A program that has not thought it through will improvise an answer in the meeting. Listen for the difference.

• Who inside the agency will see this, by role, and who makes that decision?
• Where is it stored, and is it separated from general matching notes and profile content?
• How is it transmitted to the clinic, to the carrier’s physician and to her attorney?
• What appears in any profile, portal or document the carrier’s family or friends could see?
• Is it ever used in analytics, event lists, case studies or marketing material, in any form?
• What happens to the record after the journey ends, and will you put that in writing?

Counseling

Counseling as support, not screening theater

LGBTQ+ third-party reproduction already involves donor, carrier, genetic-parent, disclosure and legal decisions that benefit from competent counseling. Adding a health disclosure to that mix does not make counseling a judgment on you.

Good counseling in this pathway does a few specific things. It gives each person accurate information about what the protocol involves. It gives the carrier a private setting to ask questions she might not want to ask across a table from the intended fathers. It surfaces disagreement between two fathers before contracts rather than after. And it gives you somewhere to put the part of this that is not clinical at all: the experience of explaining your health to strangers in order to have a child.

Look for a mental-health professional with experience in third-party reproduction and, ideally, in gay parenting journeys. Ask the clinic and the agency who they refer to, and whether that person is independent of them. Counseling that exists to produce a clearance letter is a different service from counseling that exists to help you, and you can usually tell which one you are being offered by the first appointment.

Clinic questions

Eight questions to ask a clinic

Ask these on the first call, before the tour and before the pricing conversation. The answers separate a program with a protocol from a program with an intention.

• Do you currently accept intended fathers living with HIV, and how often has this clinic managed that pathway?
• Which laboratory processes the specimen, and is it in-house or at another institution?
• What viral-load and infectious-disease documentation do you require, and over what look-back period?
• How is the sperm processed and tested, and what does the laboratory report back to you?
• What timeline applies before egg retrieval and embryo creation, and when does that work have to begin?
• How is FDA donor eligibility or ineligibility documented, and how is it disclosed?
• Has the gestational carrier’s medical team handled this pathway before?
• What is the backup plan if a sample cannot be cleared on schedule?

Common questions.